MO SB 1580
died on adjournmentSB 1580 - This act creates a new provision relating to the ordering and administering of ketamine for mental health purposes. The act provides that a licensed physician shall not delegate to any individual the authority to order ketamine hydrochloride for mental health purposes. Further, any licensed physician who delegates the administration of ketamine to a certified registered nurse anesthetist shall be on site and immediately available to supervise and respond during such treatment. Intravenous ketamine hydrochloride treatment for mental health purposes shall not be administered without a documented diagnosis and treatment plan from a physician. This act is identical to SB 830 (2025) and substantially similar to HB 1043 (2025). SARAH HASKINS
Missouri · 2026 Regular Session · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did MO SB 1580 pass?
No. MO SB 1580 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-02-05): Second Read and Referred S Families, Seniors and Health Committee
What is MO SB 1580 about?
MO SB 1580 is a bill in the 2026 Regular Session titled “SB 1580 - This act creates a new provision relating to the ordering and administering of ketamine for mental health purposes. The act provides that a licensed physician shall not delegate to any individual the authority to order ketamine hydrochloride for mental health purposes. Further, any licensed physician who delegates the administration of ketamine to a certified registered nurse anesthetist shall be on site and immediately available to supervise and respond during such treatment. Intravenous ketamine hydrochloride treatment for mental health purposes shall not be administered without a documented diagnosis and treatment plan from a physician. This act is identical to SB 830 (2025) and substantially similar to HB 1043 (2025). SARAH HASKINS”.
Who sponsors MO SB 1580?
Bean, Jason is the primary sponsor of MO SB 1580.
Description
SB 1580 - This act creates a new provision relating to the ordering and administering of ketamine for mental health purposes. The act provides that a licensed physician shall not delegate to any individual the authority to order ketamine hydrochloride for mental health purposes. Further, any licensed physician who delegates the administration of ketamine to a certified registered nurse anesthetist shall be on site and immediately available to supervise and respond during such treatment. Intravenous ketamine hydrochloride treatment for mental health purposes shall not be administered without a documented diagnosis and treatment plan from a physician. This act is identical to SB 830 (2025) and substantially similar to HB 1043 (2025). SARAH HASKINS
- Introduced
- —
- Latest action
- 2026-02-05 — Second Read and Referred S Families, Seniors and Health Committee
- Bill type
- bill
- Last updated
- —
Sponsors
- Bean, Jasonprimary
Committees
Not provided by source.
Action timeline
Newest first
2026-02-05
Second Read and Referred S Families, Seniors and Health Committee
reading-2,referral-committee
2026-01-20
S First Read
reading-1
Versions
- 6781S.01I - IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:25:15.077812Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MO&identifier=SB 1580. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.